Table 1 Patient data table
From: Chronic inflammation, neutrophil activity, and autoreactivity splits long COVID
Characteristics | PASC patients (n = 97) | Uncomplicated COVID recovery (n = 26) |
|---|---|---|
Sex | ||
Female | 71 (73%) | 10 (50 %) |
Male | 26 (27%) | 13 (50%) |
Age, mean (range) | 50 (21–81) | 40 (24–70) |
20–39 years | 16 (17%) | 15 (58%) |
40–59 years | 60 (63%) | 8 (31%) |
60–79 years | 18 (19%) | 3 (12%) |
>80 years | 1 (1%) | 0 (0%) |
Race/ethnicity | ||
African American/Black | 57 (59%) | 7 (27%) |
White | 27 (27%) | 14 (54%) |
Hispanic | 7 (7%) | 2 (8%) |
Asian | 2 (2%) | 3 (12%) |
Unknown | 4 (4%) | 0 (0%) |
Acute COVID-19 severity | ||
Asymptomatic | 0 | 0 |
Outpatient | 57 (59%) | 23 (88%) |
Hospitalized | 37 (39%) | 3 (12%) |
ICU-admitted | 3 (3%) | 0 |
Collection DPSO. Mean (range) | 140 (22–446) | 110 (18–304) |
0–3 months | 39 (41%) | 13 (50%) |
3–6 months | 34 (36%) | 8 (31%) |
6–12 months | 20 (21%) | 5 (19%) |
>12 months | 2 (2%)) | 0 (0%) |
PASC symptoms (self-reported) | ||
Dyspnea | 65 (68%) | Â |
Fatigue | 61 (64%) | Â |
Brain fog | 45 (47%) | Â |
Cough | 31 (33%) | Â |
Headache | 29 (31%) | Â |
Chest pain | 23 (24%) | Â |
Depression | 20 (21%) | Â |
Myalgias | 19 (20%) | Â |
Weakness | 19 (20%) | Â |
Anxiety | 18 (19%) | Â |
Anosmia/dysguesia | 15 (16%) | Â |
Arthralgias | 14 (15%) | Â |
